SP Group (SPG) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
26 Dec, 2025Executive summary
Achieved record revenue of DKK 2.922 billion in 2024, up 12.1% year-over-year, driven by strong growth in own products and strategic focus on key sectors.
Own products now account for 30% of revenue, supporting margin improvements and global expansion.
Opened a new U.S. factory, expanding injection molding capacity and reducing tariff risks.
Closed underperforming facilities in Denmark, including Neptune Plastic and Kvistgård, to optimize operations.
Strategic initiatives include acquisitions, sustainability, and increasing the share of own products.
Financial highlights
Q4 2024 revenue: DKK 727 million (+11.3%); full-year revenue: DKK 2.922 billion (+12.1%).
EBITDA for 2024: DKK 599 million (+34%); EBIT: DKK 386 million (+60%); EBT: DKK 345 million (+71.5%).
Earnings per share rose to DKK 21.6 from DKK 13; equity increased 16% to DKK 1.7 billion.
Net interest-bearing debt reduced to DKK 821 million; debt/EBITDA at 1.4; equity ratio nearly 54%.
Share return in 2024 was 45%; proposed dividend of DKK 4 per share (19.1% payout ratio).
Outlook and guidance
2025 revenue growth expected at 3%-10%, with EBITDA margin of 19%-21% and EBIT/EBT margin of 11%-13%.
Long-term ambition for 2030: DKK 4.5 billion revenue, DKK 600 million EBIT/EBT, 6%-9% annual growth.
Continued focus on organic growth, own product expansion, and selective acquisitions.
Latest events from SP Group
- Record H1 2026 growth and UK expansion led to upgraded outlook and strong margins.SPG
Q2 2026 - Record H1 2026 revenue and earnings growth led to an upgraded full-year outlook.SPG
Q2 2026 - Record Q1 2026 growth, robust outlook, and active capital returns amid global uncertainty.SPG
Q1 2026 - Record Q1 2026 revenue and profit growth, outlook and guidance remain robust.SPG
Q1 2026 - Record Q4 and strong 2026 growth outlook, boosted by Idé-Pro acquisition.SPG
Q4 2025 - Record Q4 and Idé-Pro acquisition set stage for strong 2026 growth amid ongoing uncertainties.SPG
Q4 2025 - H1 2025 saw lower revenue and earnings, but margin guidance and growth projects remain on track.SPG
Q2 2025 - Strong H1 2024 growth, upgraded outlook, and international expansion led by healthcare sales.SPG
Q2 2024 - Q1 2025 delivered 8.8% revenue growth and margin expansion, with outlook unchanged.SPG
Q1 2025